Recent research in Nature Genetics reveals pervasive biases in GWAX studies using parental history of Alzheimer’s, ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab ...

Insomnia, sleep apnea and disrupted sleep cycles can accelerate cognitive decline and make dementia worse, a new report on ...

Scientists have grown tiny human brains in space to research new treatments for Alzheimer's, Parkinson's and spinal injuries.

Want to tell New Mexico In Depth about your or a loved one’s experiences as a resident or caregiver at a N.M. eldercare ...

Alzheimer’s is a devastating brain disease that affects nearly seven million Americans, but sometimes, it’s misdiagnosed.

Obesity and visceral fat are associated with measures of amyloid burden in the brain among cognitively normal midlife ...

Researchers at Columbia University Mailman School of Public Health have developed a novel computational pipeline designed to ...

Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its ...

The U.S. Senate recently passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024, bipartisan legislation. The original bill signed into law in 2018 ...

Evidence of CTE -- a degenerative brain disease that can be diagnosed only at autopsy -- was found in 19.2% of donors who ...

Early signs of dementia can include memory loss, confusion and difficulty keeping up with conversations. Some may neglect ...